Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis

Mineral and Electrolyte Metabolism

Volumn 25, Issue 1-2, 1999, Pages 114-117

  Miyata, Toshio ^a   Inagi, Reiko ^a   Kurokawa, Kiyoshi ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Advanced lipoxidation end product; Amyloidosis; Dialysis; Uremia

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTICLE; CLINICAL FEATURE; DIALYSIS; DIALYSIS MEMBRANE; GLYCATION; HEMODIALYSIS; KIDNEY TRANSPLANTATION; LIPID OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; UREMIA;

AMYLOID; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID METABOLISM; OXIDATION-REDUCTION; RENAL DIALYSIS; UREMIA;

EID: 0032920580     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057432     Document Type: Article

References (21)

1. 2-Microglobulin in renal disease. J Am Soc Nephrol 1998;9:1723-1735.
2. 2-microglobulin, Biochem Biophys Res Commun 1985;129:701-706.
3. 2-microglobulin amyloidosis in haemodialysis: A prospective post-mortem study. Kidney Int 1997;51:1928-1932.
4. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993;92:1243-1252.
5. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 1996;93:2353-2358.
6. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996;7:1198-1206.
7. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW: Products of autoxidation of both carbohydrates and lipids are increased in uremic plasma. Evidence for a generalized increase in oxidative stress in uremia? Kidney Int 1998;54:1290-1295.
8. Baynes JW: Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
9. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C: Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997;12:255-258.
10. Roselaar SE, Nazhat NB, Winyard PG, Jones P. Cunnigham J, Blake DR: Detection of oxidant in uremic plasma by electron spin resonance spectroscopy. Kidney Int 1995;48: 199-206.
11. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AN, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
12. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997;51:1170-1181.
13. Esterbauer H, Schuer RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehyde. Free Radic Biol Med 1991;11:81-128.
14. 2M with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 1996;49:861-867.
15. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in non-enzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999;55:389-399.
16. Miyata T, Ueda Y, Yasuda Y, Izuhara Y, Saito A, Jadoul M, Kurokawa K, van Ypersele de Strihou C: Accumulation of carbonyls accelerates the formation of pentosidine, and advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 1998;9:2349-2356.
17. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implication for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 1996; 98:1088-1094.
18. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 1994;93:521-528.
19. 2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 1994;201:1235-1241.
20. 2-microglobulin modified with the advanced glycation end products. Kidney Int 1996;49:538-550.
21. Miyata T, Notoya K, Yoshida K, Hone K, Kurokawa K. Maeda K, Taketomi S: Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 1997;8:260-270.